Early assessment of therapeutic efficacy in lymphoma patients via a blood-based multi-omics response monitoring test
The SeekInClarity-based molecular response predicts prompt treatment efficacy and serves as a valuable complementary tool for identifying non-responders among interim PET/CT response patients.
Authors
- Zhiming Li (ORCID: https://orcid.org/0000-0001-9730-9917)
- Yinyin Chang
- Desheng Gong
- Fangyuan Chang (ORCID: https://orcid.org/0000-0001-5819-6454)
- Mingzhi Zhang (ORCID: https://orcid.org/0009-0008-5534-4042)
- Xinhua Wang (ORCID: https://orcid.org/0009-0009-1541-6854)
- Dandan Zhu (ORCID: https://orcid.org/0000-0003-4096-1909)
- Shiyong Li (ORCID: https://orcid.org/0000-0002-7052-5203)
- Wei Wu (ORCID: https://orcid.org/0009-0007-6733-0986)
- Yu Chang (ORCID: https://orcid.org/0000-0003-4774-1255)
- Mao Mao (ORCID: https://orcid.org/0000-0002-8570-8571)
Institutions
- Sun Yat-sen University (CN)
- Sun Yat-sen University Cancer Center (CN)
- First Affiliated Hospital of Zhengzhou University (CN)
- China Development Bank (CN)
Publication Details
- Journal
- BMC Cancer
- Published
- 2025-07-01
- DOI
- https://doi.org/10.1186/s12885-025-14457-6
- Citations
- 1
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.47
Funders
- Zhengzhou University
- Henan Provincial Science and Technology Research Project